Worldwide Clinical Trials is contributing its clinical research expertise to a Broad Institute-led consortium recently awarded up to $34.5 million by ARPA-H to advance gene-editing therapies for rare pediatric epilepsies. The initiative brings together leaders across science, medicine, patient advocacy, and industry to help accelerate innovative treatments for patients with significant unmet needs.
Read more here: Broad-led consortium receives ARPA-H award to advance gene editing for rare pediatric epilepsy
